PF-07921585 is under clinical development by Pfizer and currently in Phase I for Metastatic Colorectal Cancer.

BGB-10188 is under clinical development by BeiGene and currently in Phase II for Renal Cell Carcinoma. According to GlobalData, Phase II drugs for Renal Cell Carcinoma have a 29% phase transition ...

Shares of Exelixis, Inc. EXEL have surged 50% in a year against the industry’s decline of 16.1%. The stock has also ...

Dosing Schedule for Adjuvant Chemo in High-Risk Early Breast Cancer Can Be Patient’s Choice ...

How do you treat the pain of medical patients who have a history of substance use disorders? Katie Fitzgerald Jones's research into that question has made the Connell School of Nursing PhD a ...